Emerging Knowledge of the Neurobiology of COVID-19

Psychiatr Clin North Am. 2022 Mar;45(1):29-43. doi: 10.1016/j.psc.2021.11.001. Epub 2021 Nov 11.

Abstract

Many patients with COVID-19 will experience acute or longer-term neuropsychiatric complications. The neurobiological mechanisms behind these are beginning to emerge; however, the neurotropic hypothesis is not strongly supported by clinical data. The inflammatory response to SARS-CoV-2 is likely to be responsible for delirium and other common acute neuropsychiatric manifestations. Vascular abnormalities such as endotheliopathies contribute to stroke and cerebral microbleeds, with their attendant neuropsychiatric sequelae. Longer-term neuropsychiatric syndromes fall into 2 broad categories: neuropsychiatric deficits occurring after severe (hospitalized) COVID-19 and "long COVID," which occurs in many patients with a milder acute COVID-19 illness.

Keywords: COVID-19; Delirium; Long COVID; Neurobiology; Neuropsychiatry; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • COVID-19* / complications
  • Humans
  • Nervous System Diseases / virology*
  • Neurobiology
  • Post-Acute COVID-19 Syndrome
  • SARS-CoV-2